Dissecting cell biology with chemical scalpels

Current Opinion in Cell Biology

Volumn 17, Issue 1, 2005, Pages 12-19

  Hathaway, Nathaniel A ^a   King, Randall W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BLEBBISTATIN; BORTEZOMIB; BREFELDIN A; DIMINUTOL; ENZYME INHIBITOR; EPOXOMICIN; EXO 1; EXO 2; HESPERADIN; LACTACYSTIN; LEPTOMYCIN B; MG 115; MONASTROL; MYOSEVERIN; N [4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY) 4 QUINAZOLINYLAMINO]PHENYL]BENZAMIDE; NUTLIN; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN INHIBITOR; PROTEOLYSIS TARGETING CHIMERIC MOLECULE; PURVALANOL; SORTIN; SULFONAMIDE; TRAPOXIN; TUBACIN; UBISTATIN; UNCLASSIFIED DRUG; WISKOSTATIN;

CELL DIVISION; CHEMICAL GENETICS; CYTOLOGY; CYTOSKELETON; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW;

ANIMALS; BIOCHEMISTRY; BIOLOGY; CELL DIVISION; CYTOSKELETON; GENE LIBRARY; HUMANS; MODELS, BIOLOGICAL; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; UBIQUITIN;

EID: 12344324701     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2004.12.004     Document Type: Review

References (48)

1. T.J. Mitchison Towards a pharmacological genetics Chem Biol 1 1994 3 6
2. A.C. Bishop, O. Buzko, and K.M. Shokat Magic bullets for protein kinases Trends Cell Biol 11 2001 167 172
3. M.A. Jordan, and L. Wilson Microtubules as a target for anticancer drugs Nat Rev Cancer 4 2004 253 265
4. J.R. Peterson, and T.J. Mitchison Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton Chem Biol 9 2002 1275 1285
5. J.R. Peterson, R.S. Lokey, T.J. Mitchison, and M.W. Kirschner A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions Proc Natl Acad Sci USA 98 2001 10624 10629
6. J.R. Peterson, L.C. Bickford, D. Morgan, A.S. Kim, O. Ouerfelli, M.W. Kirschner, and M.K. Rosen Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation Nat Struct Mol Biol 11 2004 747 755 A forward chemical genetic screen identifies a synthetic molecule that inhibits actin assembly in extracts. NMR studies demonstrate how the molecule stabilizes N-WASP in an autoinhibited conformation.
7. N.S. Gray, L. Wodicka, A.M. Thunnissen, T.C. Norman, S. Kwon, F.H. Espinoza, D.O. Morgan, G. Barnes, S. LeClerc, and L. Meijer Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors Science 281 1998 533 538
8. O.D. Perez, Y.T. Chang, G. Rosania, D. Sutherlin, and P.G. Schultz Inhibition and reversal of myogenic differentiation by purine-based microtubule assembly inhibitors Chem Biol 9 2002 475 483
9. G.R. Rosania, Y.T. Chang, O. Perez, D. Sutherlin, H. Dong, D.J. Lockhart, and P.G. Schultz Myoseverin, a microtubule-binding molecule with novel cellular effects Nat Biotechnol 18 2000 304 308
10. S.M. Wignall, N.S. Gray, Y.T. Chang, L. Juarez, R. Jacob, A. Burlingame, P.G. Schultz, and R. Heald Identification of a novel protein regulating microtubule stability through a chemical approach Chem Biol 11 2004 135 146 This paper describes a forward chemical genetic screen for inhibitors of mitotic spindle assembly and identifies the quinone oxidoreductase NQO1 as a potential novel modulator of microtubule dynamics.
11. C.M. Grozinger, and S.L. Schreiber Deacetylase enzymes: biological functions and the use of small-molecule inhibitors Chem Biol 9 2002 3 16
12. R. Furumai, Y. Komatsu, N. Nishino, S. Khochbin, M. Yoshida, and S. Horinouchi Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin Proc Natl Acad Sci USA 98 2001 87 92
13. C. Hubbert, A. Guardiola, R. Shao, Y. Kawaguchi, A. Ito, A. Nixon, M. Yoshida, X.F. Wang, and T.P. Yao HDAC6 is a microtubule-associated deacetylase Nature 417 2002 455 458
14. A. Matsuyama, T. Shimazu, Y. Sumida, A. Saito, Y. Yoshimatsu, D. Seigneurin-Berny, H. Osada, Y. Komatsu, N. Nishino, and S. Khochbin In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation EMBO J 21 2002 6820 6831
15. A. Palazzo, B. Ackerman, and G.G. Gundersen Cell biology: tubulin acetylation and cell motility Nature 421 2003 230
16. S.J. Haggarty, K.M. Koeller, J.C. Wong, C.M. Grozinger, and S.L. Schreiber Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation Proc Natl Acad Sci USA 100 2003 4389 4394 This paper describes the discovery of tubacin as a specific inhibitor of HDAC6. Tubacin inhibits tubulin deacetylation while not affecting histone acetylation levels or gene expression significantly.
17. S.J. Haggarty, K.M. Koeller, J.C. Wong, R.A. Butcher, and S.L. Schreiber Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays Chem Biol 10 2003 383 396
18. K.M. Koeller, S.J. Haggarty, B.D. Perkins, I. Leykin, J.C. Wong, M.C. Kao, and S.L. Schreiber Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation Chem Biol 10 2003 397 410
19. J.C. Wong, R. Hong, and S.L. Schreiber Structural biasing elements for in-cell histone deacetylase paralog selectivity J Am Chem Soc 125 2003 5586 5587
20. T.U. Mayer, T.M. Kapoor, S.J. Haggarty, R.W. King, S.L. Schreiber, and T.J. Mitchison Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen Science 286 1999 971 974
21. T.M. Kapoor, T.U. Mayer, M.L. Coughlin, and T.J. Mitchison Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5 J Cell Biol 150 2000 975 988
22. Z. Maliga, T.M. Kapoor, and T.J. Mitchison Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5 Chem Biol 9 2002 989 996
23. J.C. Canman, L.A. Cameron, P.S. Maddox, A. Straight, J.S. Tirnauer, T.J. Mitchison, G. Fang, T.M. Kapoor, and E.D. Salmon Determining the position of the cell division plane Nature 424 2003 1074 1078 By overriding the spindle checkpoint in monastrol-treated cells, this study demonstrates the ability of mammalian cells to undergo cytokinesis without forming a bipolar spindle.
24. •].)
25. M.A. Lampson, K. Renduchitala, A. Khodjakov, and T.M. Kapoor Correcting improper chromosome-spindle attachments during cell division Nat Cell Biol 6 2004 232 237 An excellent application of chemical tools, this work uses multiple inhibitors to demonstrate the role of Aurora kinase in correcting attachment of mal-oriented chromosomes.
26. C. Ditchfield, V.L. Johnson, A. Tighe, R. Ellston, C. Haworth, T. Johnson, A. Mortlock, N. Keen, and S.S. Taylor Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores J Cell Biol 161 2003 267 280 This paper characterizes ZM447439 as an inhibitor of Aurora kinase and demonstrates a potential requirement for Aurora B in BubR1 regulation.
27. E.A. Harrington, D. Bebbington, J. Moore, R.K. Rasmussen, A.O. Ajose-Adeogun, T. Nakayama, J.A. Graham, C. Demur, T. Hercend, and A. Diu-Hercend VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo Nat Med 10 2004 262 267
28. T.U. Tanaka, N. Rachidi, C. Janke, G. Pereira, M. Galova, E. Schiebel, M.J. Stark, and K. Nasmyth Evidence that the Ipl1-Sli15 (Aurora kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections Cell 108 2002 317 329
29. A.F. Straight, A. Cheung, J. Limouze, I. Chen, N.J. Westwood, J.R. Sellers, and T.J. Mitchison Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor Science 299 2003 1743 1747 This paper describes the discovery of blebbistatin as a specific inhibitor of nonmuscle myosin II.
30. M. Kovacs, J. Toth, C. Hetenyi, A. Malnasi-Csizmadia, and J.R. Sellers Mechanism of blebbistatin inhibition of myosin II J Biol Chem 279 2004 35557 35563
31. J. Rosenblatt, L.P. Cramer, B. Baum, and K.M. McGee Myosin-II-dependent cortical movement is required for centrosome separation and positioning during mitotic spindle assembly Cell 117 2004 361 372 Blebbistatin is used along with biochemical and genetic techniques to demonstrate that myosin II is required for proper assembly of the mitotic spindle.
32. N. Kudo, B. Wolff, T. Sekimoto, E.P. Schreiner, Y. Yoneda, M. Yanagida, S. Horinouchi, and M. Yoshida Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1 Exp Cell Res 242 1998 540 547
33. N. Kudo, N. Matsumori, H. Taoka, D. Fujiwara, E.P. Schreiner, B. Wolff, M. Yoshida, and S. Horinouchi Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region Proc Natl Acad Sci USA 96 1999 9112 9117
34. P. Chardin, and F. McCormick Brefeldin A: the advantage of being uncompetitive Cell 97 1999 153 155
35. T.R. Kau, F. Schroeder, S. Ramaswamy, C.L. Wojciechowski, J.J. Zhao, T.M. Roberts, J. Clardy, W.R. Sellers, and P.A. Silver A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells Cancer Cell 4 2003 463 476 An extensive screen for small molecules affecting the localization of FOXO1a identifies many inhibitors of nuclear export and PI3-kinase signaling, including molecules that implicate calmodulin as a novel regulator of FOX1Oa localization.
36. •] and [38].)
37. Y. Feng, A.P. Jadhav, C. Rodighiero, Y. Fujinaga, T. Kirchhausen, and W.I. Lencer Retrograde transport of cholera toxin from the plasma membrane to the endoplasmic reticulum requires the trans-Golgi network but not the Golgi apparatus in Exo2-treated cells EMBO Rep 5 2004 596 601 Exo2 is used as a tool to demonstrate that cholera toxin can be transported from the plasma membrane to the endoplasmic reticulum in the absence of a functional Golgi apparatus.
38. T.J. Nieland, Y. Feng, J.X. Brown, T.D. Chuang, P.D. Buckett, J. Wang, X.S. Xie, T.E. McGraw, T. Kirchhausen, and M. Wessling-Resnick Chemical genetic screening identifies sulfonamides that raise organellar pH and interfere with membrane traffic Traffic 5 2004 478 492
39. J. Zouhar, G.R. Hicks, and N.V. Raikhel Sorting inhibitors (sortins): chemical compounds to study vacuolar sorting in Arabidopsis Proc Natl Acad Sci USA 101 2004 9497 9501
40. C.M. Pickart Back to the future with ubiquitin Cell 116 2004 181 190
41. A.F. Kisselev, and A.L. Goldberg Proteasome inhibitors: from research tools to drug candidates Chem Biol 8 2001 739 758
42. J. Adams The proteasome: a suitable antineoplastic target Nat Rev Cancer 4 2004 349 360
43. R. Verma, N.R. Peters, M. D'Onofrio, G.P. Tochtrop, K.M. Sakamoto, R. Varadan, M. Zhang, P. Coffino, D. Fushman, and R.J. Deshaies Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain Science 306 2004 117 120 This forward chemical genetic screen in Xenopus extracts identifies new inhibitors of cell cycle progression, including ubistatin, which binds specifically to lysine 48-linked ubiquitin chains, disrupting recognition and subsequent destruction by the proteasome.
44. L.T. Vassilev, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, and C. Klein In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 303 2004 844 848
45. K.M. Sakamoto, K.B. Kim, A. Kumagai, F. Mercurio, C.M. Crews, and R.J. Deshaies Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F-box complex for ubiquitination and degradation Proc Natl Acad Sci USA 98 2001 8554 8559
46. K.M. Sakamoto, K.B. Kim, R. Verma, A. Ransick, B. Stein, C.M. Crews, and R.J. Deshaies Development of PROTACS to target cancer-promoting proteins for ubiquitination and degradation Mol Cell Proteomics 2 2003 1350 1358
47. J.S. Schneekloth Jr., F.N. Fonseca, M. Koldobskiy, A. Mandal, R. Deshaies, K. Sakamoto, and C.M. Crews Chemical genetic control of protein levels: selective in vivo targeted degradation J Am Chem Soc 126 2004 3748 3754
48. G.P. Tochtrop, and R.W. King Target identification strategies in chemical genetics Comb Chem High Throughput Screen 7 2004 677 688